ClinicalTrials.govpublic full text
Granulocyte-macrophage Colony-stimulating Factor, Interferon and Interleukin-2 as Adjuvant Treatment for Renal Cancer
renal cell carcinoma, kidney cancer, high risk, adjuvant therapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 967717
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.